The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| MGTX | +23.34% | -45.36% | -11.38% | -45% |
| S&P | +13.19% | +87.83% | +13.42% | +142% |
MeiraGTx Holdings Plc engages in the development of novel gene therapy treatments. The company was founded on March 20, 2015 and is headquartered in New York, NY.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $0.41M | -96.2% |
| Gross Profit | -$3.06M | 29.4% |
| Gross Margin | -746.10% | -706.4% |
| Market Cap | $662.08M | 105.1% |
| Market Cap / Employee | $1.74M | 0.0% |
| Employees | 381 | -10.4% |
| Net Income | -$50.51M | -28.4% |
| EBITDA | -$42.90M | -16.6% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $14.84M | -87.9% |
| Accounts Receivable | $2.81M | -14.4% |
| Inventory | 0 | 0.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $11.53M | -86.0% |
| Short Term Debt | $76.53M | 1729.5% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -69.00% | -37.9% |
| Return On Invested Capital | -52.23% | -14.7% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$12.83M | 50.2% |
| Operating Free Cash Flow | -$12.22M | 51.2% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 4.94 | 7.84 | 15.64 | 223.70 | 6538.04% |
| Price to Sales | 14.35 | 15.53 | 13.86 | 24.30 | 13.31% |
| Price to Tangible Book Value | 4.99 | 7.93 | 16.02 | 298.50 | 8650.33% |
| Enterprise Value to EBITDA | -16.14 | -14.29 | -13.79 | -17.24 | 141.47% |
| Return on Equity | -143.5% | -216.1% | -379.5% | -611.4% | 550.49% |
| Total Debt | $84.80M | $80.88M | $80.47M | $88.06M | 1.53% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
